synthenate

Botanicalexperimental

Oxedrine (Sympatol, p-synephrine) is a naturally occurring alkaloid molecule first appeared in Europe towards the end of the 1920s being sold as a drug under the brand name Sympatol. Oxedrine was then being prescribed as a remedy for a number of respiratory conditions, which include asthma, whooping cough, colds, and hay fever. More recently, synephrine gained popularity as a weight loss aid and it has become a favored component in the more popular brands of weight loss supplement stacks. This popularity can be attributed in part to the ban imposed on ephedra, to which it shares similar mechanisms of action. Most, if not all of the synephrine being sold as a dietary supplement is extracted and synthesized from the Citrus aurantium plant, more commonly known as bitter orange. Just like ephedrine, synephrine has vasoconstrictive abilities, although at a lesser potency compared to ephedrine. There is no mention of synephrine in editions of Drill's Pharmacology in Medicine later than the 3rd, nor is there any reference to synephrine in the 2012 Physicians' Desk Reference, nor in the current FDA "Orange Book". One current reference source describes synephrine as a vasoconstrictor that has been given to hypotensive patients, orally or by injection, in doses of 20–100 mg. — NCATS

Clinical trial activity

1 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2011 (NCT01423019)

Timeline

No events for the selected filters.

Indications

Approved for

Chemistry & pharmacology

Loading structure…

SMILES

CNCC(O)C1=CC=C(O)C=C1
Mol. weight
167.205 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • analeptin
  • dl-synephrine
  • oxedrine
  • oxedrine
  • oxedrine
  • oxedrine
  • oxedrine hcl
  • oxedrine hydrochloride
  • oxedrine tartrate
  • parasympatol
  • p-synephrine
  • p-synephrine
  • p-synephrine
  • p-synephrine
  • p-synephrine
  • p-synephrine
  • p-synephrine
  • simpatol
  • sympaethamin
  • sympaethamine
  • synephrine
  • synephrine
  • synephrine
  • (±)-synephrine
  • (±)-synephrine
  • synthenate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01423019N/AOct 1, 2011Creighton University, Georgetown University, Integrative Health Technologies
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Creighton UniversityAcademic/Hospital1012011
Georgetown UniversityAcademic/Hospital1012011
Integrative Health TechnologiesFor profit1112011
3 organizations
Page 1 / 1